Načítá se...
Does the nicotine metabolite ratio moderate smoking cessation treatment outcomes in real‐world settings? A prospective study
BACKGROUND AND AIMS: In smoking treatment trials comparing varenicline with transdermal nicotine replacement therapy (NRT), stratified by nicotine metabolite (3‐hydroxycotinine/cotinine) ratio (NMR), the relative benefit of varenicline is greater among normal rather than slow metabolizers. This stud...
Uloženo v:
| Vydáno v: | Addiction |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6492100/ https://ncbi.nlm.nih.gov/pubmed/30276911 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/add.14450 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|